![BSGCT [Development]](https://cjamwebdemo.co.uk/wp-content/uploads/2025/01/BSGCT-Logo-2024-UPDATE.png){kind=logo}
Author: Robyn Bell, Imperial College London, 19 May 2021 Chronic pain has a high prevalence globally, with estimates of 20-30% of the population in Europe and the United States suffering from recurrent or persistent pain¹ ². Yet treatment options for…
Author: Gerry McLachlan, 3rd March 2021 The role for the BSGCT in engaging with the public is becoming ever more important as an increasing number of gene and cell therapies are either licensed for clinical use or are currently in,…
Author: Anitta Rose Chacko Technologies such as CRISPR have revolutionised precision genome editing and paved the way for treatment of previously incurable diseases and the generation of accurate disease models. Remarkably, a new study conducted by Mok et al., recently…
Author: Katie Dale With the huge effort that’s currently being spent developing more resistant T cell therapies with new targets and increased efficacy against solid tumours, it’s easy to overlook the toxicity concerns and the innovative ways scientists are tackling…
By Vered Smith Glaucoma is a condition that affects approximately 70 million people worldwide¹, –a number greater than all the people living in the U. K². But scientists led by Jiahui Wu from the University of Bristol, have come up…
By Anitta Rose Chacko Most of us may have experienced feeling on edge whilst playing the classic tumbling tower game of Jenga. Particularly, when it is your turn to remove a block from the tower and place it on the…
By Felicity Crawshay-Williams Before the start of World War ll in 1939, it became apparent to the Allies that the Germans were transmitting encrypted radio messages. Polish intelligence later informed the British that the secret messages took the form of…
By Christopher Smith Hello reader, I hope that you’re well, And that you have a few moments to dwell, To learn about my Post Doc project, And to rhyming you don’t object! My research focuses on a specific gene, Over…
Author: Dr Mustafa M. Munye, 6th May 2020 A recent paper from Carl June’s lab published in the journal Science¹ described results of a University of Pennsylvania clinical trial that administered in three patients T-cells engineered to target cancer cells…
Author: Dr Christos Georgiadis, 18th December 2019 A broad range of genome editing tools are currently available enabling targeted scission at a predetermined DNA locus. The field has exploded with the invention of CRISPR allowing scientists to cheaply and rapidly…